International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment…
One expert group recommends 1-2 grams of EPA a day for depression while the Cochrane review says the evidence is very low certainty — which of those should guide what I actually do?
Reasonable evidence with real limitations. how we score evidence
Caveat on this rating: ISNPR is a society organised around nutritional psychiatry, so it is the proponent of the intervention it is writing guidelines for, and the panel includes investigators whose own omega-3 trials form part of the evidence base being summarised. Two letters challenging the guideline appeared in the same journal (Psychother Psychosom 2020;89(1):48, PMID 31655818, and the authors' reply at 89(1):49, PMID 31743919). No funding statement was located, so funding is recorded UNKNOWN.
Fish-oil, EPA and DHA products sold for mood are dietary supplements under DSHEA: no FDA review of safety or effectiveness happens before they go on sale, and none is approved to treat depression or any other psychiatric condition. Prescription omega-3 drugs do exist, but for lipids, not mood.
An expert panel convened by the International Society for Nutritional Psychiatry Research used a literature review and Delphi consensus process to recommend, for major depressive disorder, either pure EPA or an EPA/DHA formula with a ratio above 2:1, at 1-2 g of net EPA daily, alongside proper diagnosis, measurement-based assessment, and monitoring for gastrointestinal and skin side effects. This is consensus expert opinion rather than new trial evidence, and it sits uneasily beside the Cochrane review's verdict that the certainty of the evidence is low to very low.
Worth asking
One expert group recommends 1-2 grams of EPA a day for depression while the Cochrane review says the evidence is very low certainty — which of those should guide what I actually do?
Source
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. — Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, et al. (2019)
Reputable peer-reviewed journal
Read the source: https://doi.org/10.1159/000502652
DOI: 10.1159/000502652
How this was scored
- Study design
- National clinical guideline
- Funding
- Funding not disclosed
- Published in
- Reputable peer-reviewed journal
- Sample size
- not recorded
- Preregistered
- No
- Conflicts disclosed
- No
- Independent of proponent
- No
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "moderate evidence". Reasonable evidence with real limitations. It scores 60 out of 100 on our published rubric. One caveat travels with that badge: ISNPR is a society organised around nutritional psychiatry, so it is the proponent of the intervention it is writing guidelines for, and the panel includes investigators whose own omega-3 trials form part of the evidence base being summarised. Two letters challenging the guideline appeared in the same journal (Psychother Psychosom 2020;89(1):48, PMID 31655818, and the authors' reply at 89(1):49, PMID 31743919). No funding statement was located, so funding is recorded UNKNOWN. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. — Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, et al. (2019). Published in: Reputable peer-reviewed journal. DOI: 10.1159/000502652. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: National clinical guideline. Funding: Funding not disclosed. The researchers were not independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is omega-3, fish oil, epa, dha, n-3 pufa, omega-3 fatty acids, krill oil, algal oil FDA approved for this use?
No. Its current status is: Not FDA-evaluated for this use. Fish-oil, EPA and DHA products sold for mood are dietary supplements under DSHEA: no FDA review of safety or effectiveness happens before they go on sale, and none is approved to treat depression or any other psychiatric condition. Prescription omega-3 drugs do exist, but for lipids, not mood.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.